Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Colorado, Denver
Medical College of Wisconsin
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Institute of Hematology & Blood Diseases Hospital, China
Memorial Sloan Kettering Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Baptist Health South Florida
Beijing Boren Hospital
Beijing Boren Hospital
Institute of Hematology and Blood Transfusion, Czech Republic
Loyola University
Washington University School of Medicine
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Therapeutic Advances in Childhood Leukemia Consortium
Stanford University
St. Anna Kinderkrebsforschung
New Mexico Cancer Research Alliance
Duke University
University of Nebraska
Rutgers, The State University of New Jersey
University of Pennsylvania
University of Birmingham
Dr Cipto Mangunkusumo General Hospital
Fred Hutchinson Cancer Center
University of California, San Diego
Wake Forest University Health Sciences
Gruppo Italiano Malattie EMatologiche dell'Adulto
Indiana University
Brown University
University of British Columbia
OHSU Knight Cancer Institute
Therapeutic Advances in Childhood Leukemia Consortium
PETHEMA Foundation
M.D. Anderson Cancer Center